RESUMEN

PURPOSE: Conjunctivitis is one of the most common ocular pathologies. Its treatment depends on its etiology, but an excessive use of antibiotics and corticosteroids, which in many cases are contraindicated, has been described. The objective was to describe the prescription patterns of medications used to treat conjunctivitis in a Colombian population. METHODS: This was a cross-sectional study on the pharmacological treatment of patients diagnosed with conjunctivitis between April 1, 2020, and March 31, 2021; based on a drug-dispensing database of approximately 8.5 million people affiliated with the Colombian Health System. Some sociodemographic and pharmacological variables and comorbidities were considered. A descriptive analysis was performed. RESULTS: A total of 8708 patients were identified; they had a median age of 44.7 years, and 59.3% were women. The most common causes of conjunctivitis were unspecified (53.1%) and allergic (37.4%). The most commonly used drug was olopatadine (26.1%), followed by dexamethasone with neomycin and polymyxin B (25.0%). A total of 97.0% of the patients received ophthalmic prescriptions, while 12.8% received systemic medications. Glucocorticoids (40.3%), antibiotics (37.7%) and antihistamines (31.7%) were the most commonly used groups of ophthalmic drugs. Glucocorticoids and ophthalmic antibiotics were the medications most frequently prescribed by general practitioners for the treatment of viral or bacterial conjunctivitis. CONCLUSIONS: Many patients with conjunctivitis are not being managed according to the recommendations of clinical practice guidelines, which highlights that the widespread use of antibiotics with ophthalmic glucocorticoids could be considered potentially inappropriate prescriptions in many cases.

Asunto(s)

Asunto(s)

Asunto(s)

Asunto(s)

Asunto(s)

RESUMEN

Introducción: el diagnóstico y tratamiento del cáncer de mama son acontecimientos estresantes que producen en las pacientes dificultades psicopatológicas y un detrimento de su calidad de vida. Métodos: se realizó un estudio cuantitativo descriptivo transversal en 58 mujeres entre 35 y 65 años, diagnosticadas con cáncer de mama que recibían tratamiento en‘Oncólogos del Occidente S.A., Pereira’. Se aplicó una encuesta que evaluó: saludfísica, psicológica, relaciones sociales y vida sexual. Se realizaron distribucionesde frecuencias y análisis univariados y bivariados para las variables demográficas, y prueba de hipótesis para el puntaje global del test. El cuestionario fue validado a través de una prueba piloto y un análisis de confiabilidad interna, cuando se incluía y excluía la pregunta de actividad sexual en las respuestas (Alfa deChrombach=0.703 y 0.77 respectivamente). Resultados: la mayoría de las mujeres reportaban una calidad de vida “buena” (T= 24.9 y significancia estadística <0.0001). Los puntajes variaron según la actividad sexual. El 20,06% de las mujeres sexualmente activas tenían una calidadde vida muy buena, 52,9% buena y 23,5% regular; mientras que en la población sexualmente inactiva se evidenció que el 29,2% es muy buena, en el 54,2% es buena y en el 12,5% es regular. El mayor deterioro fue en la actividad física máxima, donde el 41.4% respondió: actividad ligera.Conclusión: más de la mitad de las pacientes en tratamiento para cáncer de seno sexualmente activas e inactivas de la institución Oncólogos de Occidente S.A, tienen una calidad de vida en el rango “Buena”.

Introduction: breast cancer diagnosis and treatment are stressing occurrences that generate psychopathological difficulties in patients and a detriment in their quality of life.Methods: a cross-sectional study was performed in 58 women ages 35 to 65 who were diagnosed with breast cancer. The women received treatment at "Oncologos de Occidente S.A" in Pereira. The information was gathered using a survey that asked about: physical and psychological health, social relations and sexual behavior. Data was tabulated using "Microsoft Excel 2007" and analyzed with "SPSS version 17.0." Frequency distributions, univariate and bivariate analysis for demographic variables were performed; hypothesis testing was done over the mean score obtained in the tests. The questionnaire was validated through a pilot test and the analysis of its internal reliability when including or not the question about sexual activity (Chrombach's alpha= 0.703 and 0.77 respectively).Results: most of the women reported their quality of life as "good" (T = 24.9 and statistical significance <0.0001). Scores varied depending on the sexual behavior, 20.06 % of sexually active women revealed a "very good" life's quality, 52.9 % reported as "good" and 23.5 % as "regular" whereas the sexually inactive women population statistical analysis revealed life's quality as "very good" for a 29.2 %, "good" for the 54.2 % and "regular" for a 12.5 %. The most deteriorated aspect was "physical activity" reported in a 41.4% as "light activity".Conclusion: quality of life for active and inactive sexual life patients of the institution "Oncologos de Occidente S.A" was reported as "good".

Introdução: o diagnóstico e tratamento do câncer de mama são acontecimentos estressantes que produzem dificuldades psicopatológicas nos pacientes e um detrimento em sua qualidade de vida.Métodos: realizou-se um estudo comparativo descritivo transversal em 58 mulheres entre 35 e 65 anos, diagnosticadas com câncer de mama, que recebiam tratamento em "Oncólogos do Ocidente S.A., Pereira". Aplicou-se uma pesquisa que avaliou saúde física, psicológica, relações sociais e vida sexual. Foram realizadas distribuições de frequências e nálises univariadas e bivariadas para as variáveis demográficas, e prova de hipótese para a pontuação global do teste. O questionário foi avaliado através de uma prova piloto e uma análise de confiabilidade interna, quando se incluía e excluía a pergunta de atividade sexual nas respostas (Alfa de Chrombach=0.703 e 0.77 respectivamente).Resultados: a maioria das mulheres reportavam uma qualidade de vida "boa" (T=24.9 e significancia estatística <0.0001). As pontuações variaram segundo a atividade sexual. Os 20.06% das mulheres sexualmente ativas tinham uma qualidade de vida muito boa; 52.9% boa e 23.5% regular. Já na população sexualmente inativa, evidenciou-se que 29,2% é muito boa, para 54,2% é boa e para 12,5%, é regular. A maior deterioração foi na atividade física máxima, onde 41,4% respondeu: atividade ligeira.Conclusão: mais da metade das pacientesem tratamento para câncer de seio sexualmente ativas e inativas da instituição Oncólogos de Ocidente S.A., tem uma qualidade de vida na categoria "Boa".

Asunto(s)